A study done by researchers at the University of Glasgow, Scotland, shows long-term risk reduction for heart disease with metformin diabetes medication in middle-aged type 1 diabetes (T1D) patients who are with increased cardiovascular diseases (CVD) risk factors. In the REMOVAL trial, researchers used ultrasound to measure atherosclerosis of the carotid arteries in the neck area, which supply blood to neck, face and brain. The total number of adult participants in the REMOVAL trial were 428 with more than 40 years of age and having long-standing type 1 diabetes (T1D) complication. The participants in the trial had at least three of the following cardiovascular diseases (CVD) risk factors.
During the 3 years duration REMOVAL trial period, the participants were under either metformin or matching placebo medication. Researchers observed following in the participants during the trial.
Researchers attributed a reduction in atherosclerosis to metformin drug treatment, which reduced body weight and cholesterol levels. Researchers say REMOVAL trial shows heart disease risk reduction in type 1 diabetes (T1D) patients with the metformin medication. They also say guidelines should be updated as their study shows metformin drug reduces blood sugar or glucose levels for a very short period of time. The chief investigator of the study was Professor John Petrie, MD, PhD, at the University of Glasgow, Scotland. The study findings were presented to the American Diabetes Association during 77th Scientific Sessions, San Diego Convention Center, United States. The study findings were published June 11, 2017, in The Lancet Diabetes & Endocrinology. Title of the article was "Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomized, placebo-controlled trial".
The Heart Foundation, Australia says there is an enhanced risk of future heart diseases in those women who suffered preeclampsia or gestational hypertension during pregnancy. Ms. Julie Anne Mitchell, national spokeswoman for women's heart health of The Heart Foundation, Australia says those women should monitor their heart health after pregnancy. They call pregnancy as an "ultimate cardiac stress test". In Australia, studies show during pregnancy, around 30,000 women develop high blood pressure and 10,000 of them with preeclampsia condition. This dangerous complication forces the heart to work harder. Earlier studies show following enhanced future complications with preeclampsia or gestational hypertension.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.